Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)

Synonyms: GC33

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is an ADC targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)

CAS No. 1365267-33-9

Purity & Quality Control

Biological Activity

Description Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is an ADC targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.

Product Details

CAS No. 1365267-33-9
Molecular Weight 145.58
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) | Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) supplier | purchase Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) | Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) cost | Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) manufacturer | order Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) | Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) distributor